Microbial and Human Determinants of the Onset of IBD Flares

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Ulcerative ColitisCrohn DiseaseIrritable BowelCrohns Disease AggravatedCrohn Disease in Remission
Trial Locations (1)

98011

Viome Life Sciences, Bothell

All Listed Sponsors
lead

Viome

INDUSTRY